Donate now

Hilary Robbins Scientist
Genomic Epidemiology

Speciality: Translational epidemiology
Year Degree Major Institution Country/Town
2018 PhD Epidemiology Johns Hopkins Bloomberg School of Public Health USA / Baltimore
2017 MHS Biostatistics Johns Hopkins Bloomberg School of Public Health USA / Baltimore
2012 MSPH International Health Johns Hopkins Bloomberg School of Public Health USA / Baltimore
2010 BS Chemistry Duke University USA / Durham
Current Research Projects

Risk prediction and biomarkers for early detection of lung cancer

HPV biomarkers for early detection of oropharyngeal and anogenital cancers

Selected Publications

Robbins HA, Callister M, Sasieni P, et al. Benefits and harms in the National Lung Screening Trial: expected outcomes with a modern management protocol. Lancet Respir Med 2019;7(8).

Robbins HA, Berg CD, Cheung LC, Chaturvedi AK, Katki HA. Identification of candidates for longer lung cancer screening intervals following a negative low-dose computed tomography result. J Natl Cancer Inst 2019;111(9):996–9.

Robbins HA, Strickler HD, Massad LS, et al. Cervical cancer screening intervals and management for women living with HIV: a risk benchmarking approach. AIDS 2017;31(7):1035–44.

Robbins HA, Pfeiffer RM, Shiels MS, Li J, Hall HI, Engels EA. Excess cancers among HIV-infected people in the United States. J Natl Cancer Inst 2015;107(4).

Robbins HA, Clarke CA, Arron ST, et al. Melanoma risk and survival among organ transplant recipients. J Invest Dermatol 2015;135(11):2657–65.

Close Reading Mode
Publication status

Published in section: WHO'S WHO

Publication date: 25 February, 2019, 10:50

Direct link:

© Copyright International Agency on Research for Cancer 2024